Literature DB >> 9601186

Cutaneous malignant melanoma--clinical epidemiology and survival.

M K Nair1, C Varghese, S Mahadevan, T Cherian, F Joseph.   

Abstract

Melanoma of the skin is rare in the Asian population. However, this malignancy results in a high mortality due to the inadequacies in the referral pattern and management. India is one of the low incidence regions of the world. Cancer registries in India report that the age specific incidence rates for cutaneous malignant melanoma (CMM) are less than 0.5 per 1,000,000. There are only few reports in the literature on CMM in the Asian population. The Regional Cancer Centre at Trivandrum registers about 6000 new cancer cases per year and CMM forms 0.5% of them. This paper presents the clinical epidemiology and survival of 79 cases of CMM registered in the hospital cancer registry during the period 1985-90. The peak age frequency was in the 7th decade. The male:female ratio was 1.6:1. All cases had undergone a surgical manipulation in a peripheral centre, before being referred to this centre. This has posed limitation in staging and in deciding the extends of surgical excision. The overall 5-year survival rate was 25.2% (95% confidence intervals, or, CI, 14%-38%). CMM in the low incidence regions may have a different aetiology and needs to be addressed in epidemiological studies.

Entities:  

Mesh:

Year:  1998        PMID: 9601186

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN: 0019-5847


  3 in total

1.  Melanoma : A Frequently Missed Diagnosis.

Authors:  R Lakhtakia; A Mehta; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Acral lentiginous melanoma with multiple brain metastases in an Indian male.

Authors:  Kumar Parimalam; Jeyalakshmidevi Namasivayam; Subha Ramasamy; Suganthy Valavan
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

3.  Predictive factors for loco regional recurrence and distant metastasis following primary surgical treatment of cutaneous melanoma.

Authors:  Vijayalakshmi Deshmane; Mahesh Kalloli; Santosh Chikaraddi; Br Keerthi; R Krishnappa
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.